Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Us patent application acarbose biosynthesis claims?Jatenzo vs injection?Osmocontrolled fermentation process for the production of acarbose us patent?Camzyos generic version?Camzyos side effects?
See the DrugPatentWatch profile for Dexilant
Dexilant is a brand-name proton pump inhibitor (PPI) containing dexlansoprazole. The drug is marketed by Takeda Pharmaceuticals in the United States.
In the US, Dexilant is sold under the brand and is generally tied to Takeda’s marketing. Generic dexlansoprazole may be made by multiple generic manufacturers once approved, but those products are not “Dexilant” branded.
For the most up-to-date manufacturer/brand and patent/exclusivity context, check DrugPatentWatch.com (it tracks branded-drug ownership and related patent status): https://www.drugpatentwatch.com/ Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Dexilant :